MENU
SABS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
SAB Biotherapeutics (SABS) Ownership - Who owns SAB Biotherapeutics?
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum... Show more
Profile
Industry
N/A
Address
2100 East 54th Street North
Phone
+1 605 679-6980
Employees
57
Web
https://www.sabbiotherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
23.63M
P/E Ratio
N/A
Total Cash
5.71M
Projected Growth
N/A
Total Debt
6.42M
Revenue
N/A
Risk (Beta)
0.52
Dividend Yield
N/A
Total Cash/Share
0.55
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
SABS
Capitalization
23.6M
P/E Ratio
N/A
Risk (Beta)
0.52
Dividend Yield
N/A
Total Cash
5.71M
Total Cash/Share
0.55
Total Debt
6.42M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
12M
P/B Ratio
1.97
Cash Flow
N/A
Earnings
-3.99
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
936
Current Ratio
0.87
Current Revenue Per Employee
10376.80
Dividends Per Share - Security
N/A
EBITDA
-33.47M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-80.54
Shares Held By Institutions
3.92M
Shares Outstanding - Current
10.4M
Total Liabilities
18.1M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-40.435
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
2100 East 54th Street North
Phone
+1 605 679-6980
Employees
57
Web
https://www.sabbiotherapeutics.com